Imageens, a prominent French MedTech startup, had the privilege of participating in Medica 2021, where we unveiled our state-of-the-art solution, CardioInspect based on Artfun+ technology (link). This revolutionary technology is positioned to revolutionize cardiovascular risk assessment by offering predictive insights that extend up to 8.5 years into the future. This innovation is rooted in vascular aging…
Read article
Imageens is excited to announce its strategic partnership with Mieux. This collaboration aims to elevate cardiovascular health assessment through the integration of Imageens’ innovative solution, CardioInspect, into cardiovascular check-up program, “Mieux”. “Mieux” has already established itself as a gold standard in comprehensive cardiovascular check-ups, and the integration of CardioInspect will further enhance its capabilities,…
Read article
After extensive research and clinical validation, Imageens is proud to introduce CardioInspect. This marks a significant step towards providing patients with personalized and preventive medical care, ultimately striving to reshape the landscape of cardiovascular disease prevention. As designated by the World Health Organization (WHO) as a leading cause of death, cardiovascular accidents have long presented…
Read article
Paris, France – August 4, 2021 Imageens showcased its presence at the prestigious ‘Journées Francophones de Radiologie’ (JFR) 2021 by presenting its cutting-edge Cardioinspect technology. The event provided a platform to unveil the core capabilities of this groundbreaking solution. Cardioinspect is poised to redefine cardiovascular risk assessment by introducing an innovative approach, especially for patients…
Read article